210
Views
6
CrossRef citations to date
0
Altmetric
Articles

Composition and antibacterial activity of the essential oil of Artemisia nilagirica var. septentrionalis from India

, , , , , & show all
Pages 71-76 | Received 04 Aug 2014, Accepted 11 Aug 2015, Published online: 07 Oct 2015
 

Abstract

Essential oil composition of the aerial parts of Artemisia nilagirica (Clarke) Pamp. var. septentrionalis Pamp. was analyzed by GC-FID and GC-MS methods. Altogether forty-one constituents were identified, accounting for 95.9% of total composition. The essential oil was characterized by monoterpenoids (76.6%) represented by artemisia ketone (62.6%), artemisia alcohol (3.7%), perillene (3.1%), bornyl acetate (1.4%), along with sesquiterpenoids (16.1%) viz. β-caryophyllene (3.5%), α-muurolol (3.5%), δ-cadinene (2.1%) and germacrene D (1.8%). Essential oil was tested against nine pathogenic bacterial strains viz. Staphylococcus aureus (MTCC 96), Staphylococcus aureus (MTCC 2940), Streptococcus mutans, Staphylococcus epidermidis, Bacillus subtilis, Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, and Salmonella typhimurium. Based on zone of inhibition and MIC/MBC results, it is concluded that the essential oil of A. nilagirica var. septentrionalis exhibited good antibacterial activity against Staphylococcus aureus (MTCC-2940), Staphylococcus aureus (MTCC-96) and Bacillus subtilis, and moderate activity against Escherichia coli, Staphylococcus epidermidis, Salmonella typhimurium, and Streptococcus mutans.

Acknowledgments

The authors are thankful to the Director of the CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, Uttar Pradesh for facilities and encouragement, and to the CSIR for financial grant (BSC-0203).

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.